{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:40:16Z","timestamp":1784954416185,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"DOI":"10.7759\/cureus.41895","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T19:29:11Z","timestamp":1689362951000},"source":"Crossref","is-referenced-by-count":2,"title":["Treating Iron Deficiency (ID) Anemia in Heart Failure (HF) Patients with IV Iron: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Fredrick M","family":"Ogugua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco  A","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Gamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Haisum","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Kyung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedi","family":"Kasmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oubada","family":"AlKowatli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich PA","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, et al.. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013, 6:606-19. 10.1161\/HHF.0b013e318291329a","journal-title":"Circ Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004873","article-title":"National burden of heart failure events in the United States, 2006 to 2014","volume":"11","author":"Jackson SL","year":"2018","unstructured":"Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD. National burden of heart failure events in the United States, 2006 to 2014. Circ Heart Fail. 2018, 11:e004873. 10.1161\/CIRCHEARTFAILURE.117.004873","journal-title":"Circ Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip IT","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, et al.. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013, 165:575-82.e3. 10.1016\/j.ahj.2013.01.017","journal-title":"Am Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg N","year":"2018","unstructured":"Grote Beverborg N, Klip IT, Meijers WC, et al.. Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail. 2018, 11:e004519. 10.1161\/CIRCHEARTFAILURE.117.004519","journal-title":"Circ Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas JN","year":"2006","unstructured":"Nanas JN, Matsouka C, Karageorgopoulos D, et al.. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006, 48:2485-9. 10.1016\/j.jacc.2006.08.034","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.044","article-title":"Anemia and chronic heart failure implications and treatment options","volume":"52","author":"Anand IS","year":"2008","unstructured":"Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol. 2008, 52:501-11. 10.1016\/j.jacc.2008.04.044","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska EA","year":"2011","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, et al.. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail. 2011, 17:899-906. 10.1016\/j.cardfail.2011.08.003","journal-title":"J Card Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska EA","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, et al.. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010, 31:1872-80. 10.1093\/eurheartj\/ehq158","journal-title":"Eur Heart J"},{"key":"ref9","article-title":"Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting","volume":"58","author":"Varma A","year":"2010","unstructured":"Varma A, Appleton DL, Nusca A, et al.. Iron deficiency anemia and cardiac mortality in patients with left ventricular systolic dysfunction undergoing coronary stenting. Minerva Cardioangiol. 2010, 58:1-10.","journal-title":"Minerva Cardioangiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli JE","year":"2007","unstructured":"Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol. 2007, 50:1657-65. 10.1016\/j.jacc.2007.07.029","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko DO","year":"2008","unstructured":"Okonko DO, Grzeslo A, Witkowski T, et al.. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. 2008, 51:103-12. 10.1016\/j.jacc.2007.09.036","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen DJ","year":"2017","unstructured":"van Veldhuisen DJ, Ponikowski P, van der Meer P, et al.. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017, 136:1374-83. 10.1161\/CIRCULATIONAHA.117.027497","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12250","article-title":"Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)","volume":"5","author":"Yeo TJ","year":"2018","unstructured":"Yeo TJ, Yeo PS, Hadi FA, et al.. Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Fail. 2018, 5:344-53. 10.1002\/ehf2.12250","journal-title":"ESC Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2009.05.010","article-title":"A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes","volume":"15","author":"Com\u00edn-Colet J","year":"2009","unstructured":"Com\u00edn-Colet J, Ruiz S, Cladellas M, Rizzo M, Torres A, Bruguera J. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. J Card Fail. 2009, 15:727-35. 10.1016\/j.cardfail.2009.05.010","journal-title":"J Card Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski P","year":"2020","unstructured":"Ponikowski P, Kirwan BA, Anker SD, et al.. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet . 2020, 396:1895-904. 10.1016\/S0140-6736(20)32339-4","journal-title":"Lancet"},{"key":"ref18","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions. Accessed. July 14, 2023: https:\/\/training.cochrane.org\/handbook."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood L","year":"2008","unstructured":"Wood L, Egger M, Gluud LL, et al.. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008, 336:601-5. 10.1136\/bmj.39465.451748.AD","journal-title":"BMJ"},{"key":"ref20","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed. July 13, 2023: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study","volume":"37","author":"Silverberg DS","year":"2001","unstructured":"Silverberg DS, Wexler D, Sheps D, et al.. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001, 37:1775-80. 10.1016\/S0735-1097(01)01248-7","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker SD","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al.. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009, 361:2436-48. 10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski P","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J. 2015, 36:657-68. 10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"key":"ref24","unstructured":"CONSORT 2010 statement. updated guidelines for reporting parallel group randomised trials. Accessed: July 14, 2023: https:\/\/www.equator-network.org\/reporting-guidelines\/consort\/."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis GD","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, et al.. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017, 317:1958-66. 10.1001\/jama.2017.5427","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials","volume":"110","author":"Graham FJ","year":"2021","unstructured":"Graham FJ, Pellicori P, Ford I, Petrie MC, Kalra PR, Cleland JG. Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clin Res Cardiol. 2021, 110:1299-307. 10.1007\/s00392-021-01837-8","journal-title":"Clin Res Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker SD","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ, et al.. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018, 20:125-33. 10.1002\/ejhf.823","journal-title":"Eur J Heart Fail"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2019-137342","article-title":"Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials","volume":"96","author":"Zhang J","year":"2020","unstructured":"Zhang J, Hu S, Jiang Y, Zhou Y. Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials. Postgrad Med J. 2020, 96:766-76. 10.1136\/postgradmedj-2019-137342","journal-title":"Postgrad Med J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13146","article-title":"Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis","volume":"7","author":"Khan MS","year":"2020","unstructured":"Khan MS, Usman MS, von Haehling S, Doehner W, Stewart Coats AJ. Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis. ESC Heart Fail. 2020, 7:3392-400. 10.1002\/ehf2.13146","journal-title":"ESC Heart Fail"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03777-w","article-title":"Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization","volume":"98","author":"Mistry R","year":"2019","unstructured":"Mistry R, Hosoya H, Kohut A, Ford P. Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization. Ann Hematol. 2019, 98:2293-7. 10.1007\/s00277-019-03777-w","journal-title":"Ann Hematol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-17-00017","article-title":"Repeat hospitalizations predict mortality in patients with heart failure","volume":"182","author":"Lin AH","year":"2017","unstructured":"Lin AH, Chin JC, Sicignano NM, Evans AM. Repeat hospitalizations predict mortality in patients with heart failure. Mil Med. 2017, 182:e1932-7. 10.7205\/MILMED-D-17-00017","journal-title":"Mil Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)00843-6","article-title":"Overview of the treatment of heart failure","volume":"80","author":"Cohn JN","year":"1997","unstructured":"Cohn JN. Overview of the treatment of heart failure. Am J Cardiol . 1997, 80:2L-6L. 10.1016\/s0002-9149(97)00843-6","journal-title":"Am J Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon SD","year":"2005","unstructured":"Solomon SD, Anavekar N, Skali H, et al.. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005, 112:3738-44. 10.1161\/CIRCULATIONAHA.105.561423","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164889-treating-iron-deficiency-id-anemia-in-heart-failure-hf-patients-with-iv-iron-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:50Z","timestamp":1707509150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164889-treating-iron-deficiency-id-anemia-in-heart-failure-hf-patients-with-iv-iron-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.41895","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}